Excellent Drug...Waiting For Management To Reprice Trulance and Smarten Up. Trulance is superior to all other drugs and medications for IBS-C. Sadly, I have been watching a two year journey of a close family member including impactions, blockages and perhaps four unnecessary operations. This experience has provided a bellyful of first hand knowledge of this subject. Linzess was a horrible experience. Side effects caused 8 lb drop in weight in two weeks, with inability to eat because of so much gas buildup, cramps and vomiting. GI docs wanted to prescribe Trulance instead, but insurance protocols required Linzess first, plus every other method to be tried before Trulance could be prescribed. Even then, the insurance co called us for approval of the higher cost which didn't matter to me. But it showed how many hoops a patient has to jump through to get Trulance. Weeks and months of pain resulted from SGYP's mispricing. When finally, Trulance was prescribed, the improvement was immediate. She is in second week of Trulance now and already 3 lbs regained, eating again, and intestines working. If Trulance was simply repriced $1 below Linzess, GI docs would abandon Linzess, and all the roadblocks to its financial success would be removed. Why is management spending $35MM a quarter to over come this? The number of scripts would soar. GI docs know this drug and experience with patients has proved to them its efficacy with no discomfort. SPYG Management is just plain stupid and greedy, which we all have witnessed. It's egotistical to want a higher price, when Trulance could own this category and be the instant leader. It's that good. Management is that bad. I sold before the annual meeting, but just bought it back. The chart is crawling on the bottom now. There is real value in Trulance.
